You already implies you agree with my claim about it not being unreasonable when you said “as well.” I guess you retract that? And again: this study is just on

You already implies you agree with my claim about it not being unreasonable when you said “as well.” I guess you retract that? And again: this study is just one of many studies that have lead to my prior. The rate of myocarditis is well established, the population size is well established, the open question is the fatality rate. The unreasonable part comes from putting a lower bound on the death rate based on some assumptions around these studies which have done autopsies and the estimates on subclinical heart interactions from the drug. There are several studies on all of these things. The back of the napkin math to me is on the order of tens of thousands of unnecessary deaths.